Host Dave Knapp contextualizes reports of over 200 UK deaths linked to GLP-1s, analyzing the tragic case of 19-year-old Josephine Nassar to distinguish correlation from causation. He discusses actress Chrissy Metz’s public embrace of weight-loss medication and a Harvard study revealing the "obesity penalty" in hiring and relationships. Finally, Knapp addresses Starbucks’ decision to drop GLP-1 coverage for obesity, highlighting the growing tension between employer costs and patient access to chronic disease treatment.
Listen ad-free on Castria